Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 10 of 82 drugs
| No. | DrugBank | 薬物名（臨床試験情報から抽出） | KEGG DRUG | KEGG GENES | KEGG PATHWAY | 指定難病告示番号 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Acteoside | 1件: Acteoside Acteoside | - | - | - | 1件: 66 66 💬1. Acteoside
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2 | Aliskiren | 1件: Aliskiren Aliskiren | 1件: Aliskiren
Aliskiren
💬2. Aliskiren
| 1件: REN REN 💬2. Aliskiren
| 3件: Diabetic cardiomyopathy Diabetic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | 3件: 66 66, 167, 222 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 3 | Allopurinol | 2件: Allopurinol Allopurinol; ALLOPURINOL SODIUM | 1件: Allopurinol
Allopurinol
💬3. Allopurinol
| 1件: XDH XDH 💬3. Allopurinol
| 6件: Caffeine metabolism Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Peroxisome, Purine metabolism 💬 6件: Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, ... | 7件: 6 6, 46, 57, 60, 66, 96, 97 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 4 | Angiotensin II | 2件: Angiotensin Angiotensin; Angiotensin II | 2件: Angiotensin II
Angiotensin II
,Angiotensin II 💬 4. Angiotensin II
| 2件: AGTR1 AGTR1,AGTR2 💬 | 16件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, A ... | 7件: 17 17, 19, 46, 66, 86, 222, 224 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 5 | Artesunate | 1件: Artesunate Artesunate | 1件: Artesunate
Artesunate
💬5. Artesunate
| - | - | 6件: 18 18, 53, 66, 96, 215, 271 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 6 | Atacicept | 2件: Atacicept Atacicept; TACI-Fc5 | 1件: Atacicept
Atacicept
💬6. Atacicept
| 2件: TNFSF13 TNFSF13,TNFSF13B 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B ... | 4件: 13 13, 46, 49, 66 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 7 | Atrasentan | 1件: ATRASENTAN ATRASENTAN | - | - | - | 3件: 66 66, 218, 222 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 8 | Azathioprine | 3件: Azathioprine Azathioprine; Azatioprina; Imuran | 1件: Azathioprine
Azathioprine
💬8. Azathioprine
| - | - | 21件: 6 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 63, 65, 66, 85, 93, 94, 95, 96, 97, 162 💬8. Azathioprine
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 9 | Bardoxolone | 1件: Bardoxolone Bardoxolone | 1件: Bardoxolone
Bardoxolone
💬9. Bardoxolone
| - | - | 7件: 66 66, 67, 84, 85, 86, 218, 222 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 10 | Bardoxolone methyl | 1件: Bardoxolone Methyl Bardoxolone Methyl | 1件: Bardoxolone methyl
Bardoxolone methyl
💬10. Bardoxolone methyl
| - | - | 7件: 66 66, 67, 84, 85, 86, 218, 222 💬
|